BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14610340)

  • 1. Nephropathy in a hypercholesterolemic mouse model with streptozotocin-induced diabetes.
    Hammad SM; Hazen-Martin DJ; Sohn M; Eldridge L; Powell-Braxton L; Won W; Lyons TJ
    Kidney Blood Press Res; 2003; 26(5-6):351-61. PubMed ID: 14610340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy.
    Hammad SM; Powell-Braxton L; Otvos JD; Eldridge L; Won W; Lyons TJ
    Metabolism; 2003 Jul; 52(7):916-21. PubMed ID: 12870170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling.
    Takashima Y; Keino-Masu K; Yashiro H; Hara S; Suzuki T; van Kuppevelt TH; Masu M; Nagata M
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F395-408. PubMed ID: 26764203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice.
    Spencer MW; Mühlfeld AS; Segerer S; Hudkins KL; Kirk E; LeBoeuf RC; Alpers CE
    Am J Nephrol; 2004; 24(1):20-31. PubMed ID: 14671436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney.
    Falke LL; Dendooven A; Leeuwis JW; Nguyen TQ; van Geest RJ; van der Giezen DM; Broekhuizen R; Lyons K; Stoop R; Kemperman H; Schlingemann R; Joles JA; Goldschmeding R
    Matrix Biol; 2012; 31(7-8):421-31. PubMed ID: 23199377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.
    Vandekerckhove L; Vermeulen Z; Liu ZZ; Boimvaser S; Patzak A; Segers VF; De Keulenaer GW
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E495-504. PubMed ID: 26786778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
    Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
    J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of UNC5B in Kidney Epithelium Exacerbates Diabetic Nephropathy in Mice.
    Ranganathan P; Mohamed R; Jayakumar C; Brands MW; Ramesh G
    Am J Nephrol; 2015; 41(3):220-30. PubMed ID: 25896231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy.
    Fujimoto M; Maezawa Y; Yokote K; Joh K; Kobayashi K; Kawamura H; Nishimura M; Roberts AB; Saito Y; Mori S
    Biochem Biophys Res Commun; 2003 Jun; 305(4):1002-7. PubMed ID: 12767930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular injury is exacerbated in diabetic integrin alpha1-null mice.
    Zent R; Yan X; Su Y; Hudson BG; Borza DB; Moeckel GW; Qi Z; Sado Y; Breyer MD; Voziyan P; Pozzi A
    Kidney Int; 2006 Aug; 70(3):460-70. PubMed ID: 16775606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
    Rodionov RN; Jarzebska N; Schneider A; Rexin A; Sradnick J; Brilloff S; Martens-Lobenhoffer J; Bode-Böger SM; Todorov V; Hugo C; Weiss N; Hohenstein B
    Atheroscler Suppl; 2019 Dec; 40():100-105. PubMed ID: 31818438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
    Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
    Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fcγ receptor deficiency attenuates diabetic nephropathy.
    Lopez-Parra V; Mallavia B; Lopez-Franco O; Ortiz-Muñoz G; Oguiza A; Recio C; Blanco J; Nimmerjahn F; Egido J; Gomez-Guerrero C
    J Am Soc Nephrol; 2012 Sep; 23(9):1518-27. PubMed ID: 22859852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.
    Soulis-Liparota T; Cooper M; Papazoglou D; Clarke B; Jerums G
    Diabetes; 1991 Oct; 40(10):1328-34. PubMed ID: 1834497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain.
    Uil M; Scantlebery AML; Butter LM; Larsen PWB; de Boer OJ; Leemans JC; Florquin S; Roelofs JJTH
    Sci Rep; 2018 Apr; 8(1):5542. PubMed ID: 29615804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.